Adamas Reports Second Quarter 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Adamas Pharmaceuticals, Inc. (ADMS) Tops Q2 EPS by 7c
August 7, 2014 4:26 PM EDTAdamas Pharmaceuticals, Inc. (NASDAQ: ADMS) reported Q2 EPS of $0.88, $0.07 better than the analyst estimate of $0.81. Revenue for the quarter came in at $25.15 million versus the consensus estimate of $18.75 million.
For earnings history and earnings-related data on Adamas Pharmaceuticals, Inc. (ADMS) click here.
... More